Promising therapeutic target for depression identified


Thursday, 30 May, 2019

Promising therapeutic target for depression identified

Researchers from the University of Malaga (UMA) have identified what they believe to be a new therapeutic target for depression — one of the most widespread disorders that affects society today.

There are different pharmacological treatments for depression; mainly therapies that act on the serotonin system — the so-called SSRIs (selective serotonin reuptake inhibitors). However, these antidepressants typically take around two weeks to have an effect and, what’s more, around 30% of patients are resistant to this class of drug.

Now, UMA researchers have discovered that a fragment of the ‘galanin’ neuropeptide — an endogenous molecule of the brain — is involved in anhedonia, which is the loss of the capacity to feel pleasure in daily activities (including meals, social activities and sex) and is thus one of the main symptoms in depressed patients. Writing in the Journal of Psychopharmacology, the researchers described the role of ‘GAL (1-15)’ in the brain reward system of an animal model.

“We have verified through different experiments how animals modify their response to high-reinforcement appetitive stimuli, such as saccharine or sexual attraction, after the administration of the galanin fragment,” said study co-author Carmelo Millón.

The researchers analysed the brain reinforcement system at a molecular level — specifically, the circuit in charge of reinforcing positive behaviour for individuals and species — and reaffirmed that the galanin fragment acts directly on this neurological mechanism, reducing the circuit activity. Millón said describing this fragment is essential to modulating the brain reward circuit, with applications that go beyond treatments for depression — such as possible use in drug-related addictions.

“The understanding of these mechanisms opens the way for endless therapeutic strategies, hence its importance,” Millón said.

Image credit: ©stock.adobe.com/au/Kwest

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Protein-based therapy helps the body remove harmful cells

Scientists have created a protein-based therapeutic tool that could change the way we treat...

Diabetes changes the structure of our hearts, study finds

Type 2 diabetes directly alters the heart's structure and energy systems, which explains why...

Beta blockers could halt triple negative breast cancer

Researchers have identified a molecular biomarker in triple negative breast cancer tumours which...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd